(NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced its annual performance analysis of ...
Luke Walker, a director at Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL), recently acquired additional shares of the company's common stock. According to a recent SEC filing, Walker purchased 14,200 ...
The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market for deals to fill its drug pipeline and power sales growth into the 2030s, ...